MSD DANMARK ApS
CVR: 29883718
Secondary names: WARRICK LÆGEMIDLER ApS, ESSEX PHARMA ApS, SCHERING-PLOUGH ANIMAL HEALTH ApS
The financial health of MSD DANMARK ApS shows signs of decline, with revenue decreasing from 761.5 million DKK in 2021 to 337.9 million DKK in 2024. Profitability has also been impacted, dropping from 26.7 million DKK in 2022 to 14.9 million DKK in 2024, indicating a challenging market environment. Despite a solid equity position of 78.3 million DKK in 2024, the declining revenue trend raises concerns about future growth and market competitiveness. The company operates within the wholesale trade of pharmaceuticals and medical supplies, suggesting it holds a significant position, but its current trajectory may necessitate strategic adjustments to stabilize and improve financial performance.
AI-generated summary
Overview
Details
Purpose
Selskabets formål er at udøve virksomhed indenfor industri og handel samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 337.9 mio. | 14.9 mio. | 162.9 mio. | 78.3 mio. | 125 | |
History
Ownership
Management
Directors
Production units (2)
Similar companies
Companies in the same industry and area